Position history for BlackRock, Inc.'s holdings in SPYRE THERAPEUTICS INC
BlackRock, Inc. holds 5.5M shares of SYRE (SPYRE THERAPEUTICS INC), worth $180.9M as of 2025-Q4. The position was increased (++38.6% shares). SYRE represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$180.9M
Current Shares
5.5M
Total Value Change
+$101.8M
Total Shares Change
+2.1M
Other major holders of SYRE: FMR LLC, RTW INVESTMENTS, LP
Increased |
| 5.5M |
+38.6% |
| $180.9M |
| 0.0% |
| $31.88 |
40 |
| 2025-Q3 | Decreased | 4M | -0.6% | $66.8M | 0.0% | $16.36 | 0 |
| 2025-Q2 | Increased | 4M | +12.2% | $60M | 0.0% | $15.22 | 33 |
| 2025-Q1 | Increased | 3.6M | +5.1% | $57.6M | 0.0% | $17.94 | 31 |
| 2024-Q4 | New | 3.4M | - | $79.1M | 0.0% | $22.54 | 41 |